Standout Papers

Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura 2007 2026 2013 2019 550
  1. Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura (2007)
    James B. Bussel, Gregory Cheng et al. New England Journal of Medicine

Immediate Impact

3 by Nobel laureates 12 from Science/Nature 60 standout
Sub-graph 1 of 21

Citing Papers

Chemically Modified Platforms for Better RNA Therapeutics
2024 Standout
Chemically defined cytokine-free expansion of human haematopoietic stem cells
2023 StandoutNature
2 intermediate papers

Works of J.M. Jenkins being referenced

Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist
2007
Analysis of Bleeding in Patients with Immune Thrombocytopenic Purpura (ITP): A Randomized, Double-Blind, Placebo-Controlled Trial of Eltrombopag, an Oral Platelet Growth Factor.
2006
and 1 more

Author Peers

Author Last Decade Papers Cites
J.M. Jenkins 1617 1261 336 1763 109 4.8k
Craig R. Nichols 974 652 57 1049 153 6.4k
William H. Kutteh 1355 1725 264 737 139 5.3k
Antoine Dürrbach 314 1009 133 369 200 6.9k
Dominik T. Schneider 997 566 84 245 224 6.4k
S. A. Roberts 933 1122 127 154 160 6.3k
Rudi Steffensen 219 495 87 821 119 3.5k
Klaus Rostgaard 130 806 225 801 171 5.9k
Inge Clemmensen 186 548 123 911 107 4.7k
John M. Weiner 119 519 362 662 164 6.5k
Anne I. Goldman 127 734 240 1846 73 5.0k

All Works

Loading papers...

Rankless by CCL
2026